Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanakatte Raviprakash

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Methods in Molecular Medicine|September 22, 2006
Needle-free injection of DNA vaccines: a brief overview and methodologyKanakatte Raviprakash, Kevin R Porter
Current Issues in Molecular Biology|November 11, 2016
DNA Vaccine Delivery and Improved ImmunogenicityKevin R Porter, Kanakatte Raviprakash
Vaccine|October 14, 2015
Nucleic acid (DNA) immunization as a platform for dengue vaccine developmentKevin R Porter, Kanakatte Raviprakash
Methods in Molecular Biology (Clifton, N.J.)|April 10, 2014
Tetravalent DNA vaccine product as a vaccine candidate against dengueKevin R Porter, Nimfa Teneza-Mora, Kanakatte Raviprakash
Human Vaccines|June 19, 2009
Advances in dengue vaccine developmentKanakatte Raviprakash, Gabriel Defang, Timothy Burgess, et al.
Contemporary Topics in Laboratory Animal Science|September 27, 2003
Variable susceptibility of the owl monkey (Aotus nancymae) to four serotypes of dengue virusAnn M Schiavetta, Joseph G Harre, Elizabeth Wagner, et al.
Human Vaccines & Immunotherapeutics|July 10, 2013
Dengue virus photo-inactivated in presence of 1,5-iodonaphthylazide (INA) or AMT, a psoralen compound (4'-aminomethyl-trioxsalen) is highly immunogenic in miceKanakatte Raviprakash, Peifang Sun, Yossef Raviv, et al.
Human Vaccines & Immunotherapeutics|October 4, 2012
A dengue DNA vaccine formulated with Vaxfectin® is well tolerated, and elicits strong neutralizing antibody responses to all four dengue serotypes in New Zealand white rabbitsKanakatte Raviprakash, Thomas Luke, John Doukas, et al.
Journal of Virological Methods|June 19, 2017
Antibody-dependent NK cell degranulation as a marker for assessing antibody-dependent cytotoxicity against pandemic 2009 influenza A(H1N1) infection in human plasma and influenza-vaccinated transchromosomic bovine intravenous immunoglobulin therapyBrian J Morrison, Jessica A Roman, Thomas C Luke, et al.
Plos One|June 11, 2014
Dengue serosurvey in Sint EustatiusTeresa Leslie, Nicholas J Martin, Carol Jack-Roosberg, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Methods in Molecular Medicine|September 22, 2006
Needle-free injection of DNA vaccines: a brief overview and methodologyKanakatte Raviprakash, Kevin R Porter
Current Issues in Molecular Biology|November 11, 2016
DNA Vaccine Delivery and Improved ImmunogenicityKevin R Porter, Kanakatte Raviprakash
Vaccine|October 14, 2015
Nucleic acid (DNA) immunization as a platform for dengue vaccine developmentKevin R Porter, Kanakatte Raviprakash
Methods in Molecular Biology (Clifton, N.J.)|April 10, 2014
Tetravalent DNA vaccine product as a vaccine candidate against dengueKevin R Porter, Nimfa Teneza-Mora, Kanakatte Raviprakash
Human Vaccines|June 19, 2009
Advances in dengue vaccine developmentKanakatte Raviprakash, Gabriel Defang, Timothy Burgess, et al.
Contemporary Topics in Laboratory Animal Science|September 27, 2003
Variable susceptibility of the owl monkey (Aotus nancymae) to four serotypes of dengue virusAnn M Schiavetta, Joseph G Harre, Elizabeth Wagner, et al.
Human Vaccines & Immunotherapeutics|July 10, 2013
Dengue virus photo-inactivated in presence of 1,5-iodonaphthylazide (INA) or AMT, a psoralen compound (4'-aminomethyl-trioxsalen) is highly immunogenic in miceKanakatte Raviprakash, Peifang Sun, Yossef Raviv, et al.
Human Vaccines & Immunotherapeutics|October 4, 2012
A dengue DNA vaccine formulated with Vaxfectin® is well tolerated, and elicits strong neutralizing antibody responses to all four dengue serotypes in New Zealand white rabbitsKanakatte Raviprakash, Thomas Luke, John Doukas, et al.
Journal of Virological Methods|June 19, 2017
Antibody-dependent NK cell degranulation as a marker for assessing antibody-dependent cytotoxicity against pandemic 2009 influenza A(H1N1) infection in human plasma and influenza-vaccinated transchromosomic bovine intravenous immunoglobulin therapyBrian J Morrison, Jessica A Roman, Thomas C Luke, et al.
Plos One|June 11, 2014
Dengue serosurvey in Sint EustatiusTeresa Leslie, Nicholas J Martin, Carol Jack-Roosberg, et al.
Pageof 4